Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice
Psoriasis is a chronic, immune-mediated inflammatory skin disease. As psoriasis rarely occurs in nonhuman animals, the lack of an ideal animal model reflecting the histopathological and molecular immunological characteristics of psoriasis remains an urgent issue. In the present study, an imiquimod-i...
Main Authors: | Yongjian Li, Guiying Zhang, Mingliang Chen, Min Tong, Ming Zhao, Fang Tang, Rong Xiao, Haiquan Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S075333221833823X |
Similar Items
-
Progress in the Studies on Rutaecarpine
by: Yurngdong Jahng, et al.
Published: (2008-02-01) -
Fluorine-Modified Rutaecarpine Exerts Cyclooxygenase-2 Inhibition and Anti-inflammatory Effects in Lungs
by: Chiming Lee, et al.
Published: (2019-02-01) -
Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice
by: Jintao Gao, et al.
Published: (2020-10-01) -
Pharmacological Effects of Rutaecarpine as a Cardiovascular Protective Agent
by: Changping Hu, et al.
Published: (2010-03-01) -
Coexistence of psoriasis and atopic dermatitis
by: Agnieszka Terlikowska-Brzósko, et al.
Published: (2015-10-01)